Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
R. R. Chaparian, A. T. Harding, K. Riebe…·B. E. Heaton
This paper develops a combination vaccine using recombinant influenza A virus to deliver SARS-CoV-2 spike RBD, showing protection against both pathogens.
T. M. Yaron, B. E. Heaton, T. M. Levy…·M Kavanagh-Williamson
This study identifies Alectinib as an FDA-approved drug that inhibits SARS-CoV-2 nucleocapsid phosphorylation and viral replication in vitro by targeting host kinases.
R. R. Chaparian, A. S. Ball, J. C. van Kessel
This study identifies second-tier transcription factors regulated by LuxR in Vibrio harveyi and shows they control metabolic processes and cell density-dependent behaviors.
R. R. Chaparian, M. L. Tran, L. C. Miller Conrad…·J. C. van Kessel
The paper shows LuxR counteracts H-NS repression to activate quorum sensing gene expression in Vibrio harveyi by displacing H-NS from promoters.